• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单发性小肝细胞癌微创肝切除术后的短期和长期结果:来自 IGoMILS(意大利微创肝外科组)注册研究的 714 例患者分析。

Short and long-term outcomes after minimally invasive liver resection for single small hepatocellular carcinoma: An analysis of 714 patients from the IGoMILS (Italian group of minimally invasive liver surgery) registry.

机构信息

Hepatobiliary Surgery Unit, Fondazione Policlinico Universitario A. Gemelli IRCSS, Università Cattolica del Sacro Cuore, Rome, Italy.

Hepatobiliary Surgery Division, IRCCS San Raffaele Hospital, Milan, Italy.

出版信息

HPB (Oxford). 2023 Jun;25(6):674-683. doi: 10.1016/j.hpb.2023.02.007. Epub 2023 Feb 24.

DOI:10.1016/j.hpb.2023.02.007
PMID:36922259
Abstract

BACKGROUND

Widespread use of minimally invasive liver surgery (MILS) contributed to the reduction of surgical risk of liver resection for hepatocellular carcinoma (HCC). Aim of this study was to analyze outcomes of MILS for single ≤3 cm HCC.

METHODS

Patients who underwent MILS for single ≤3 cm HCC (November 2014 - December 2019) were identified from the Italian Group of Minimally Invasive Liver Surgery (IGoMILS) Registry.

RESULTS

Of 714 patients included, 641 (93.0%) were Child-Pugh A; 65.7% were limited resections and 2.2% major resections, with a conversion rate of 5.2%. Ninety-day mortality rate was 0.3%. Overall morbidity rate was 22.4% (3.8% major complications). Mean postoperative stay was 5 days. Robotic resection showed longer operative time (p = 0.004) and a higher overall morbidity rate (p < 0.001), with similar major complications (p = 0.431). Child-Pugh B patients showed worse mortality (p = 0.017) and overall morbidity (p = 0.021), and longer postoperative stay (p = 0.005). Five-year overall survival was 79.5%; cirrhosis, satellite micronodules, and microvascular invasion were independently associated with survival.

CONCLUSIONS

MILS for ≤3 cm HCC was associated with low morbidity and mortality rates, showing high safety, and supporting the increasing indications for surgical resection in these patients.

摘要

背景

微创肝切除术(MILS)的广泛应用降低了肝细胞癌(HCC)肝切除的手术风险。本研究旨在分析 MILS 治疗单个≤3cm HCC 的结果。

方法

从意大利微创肝外科组(IGoMILS)登记处确定了 2014 年 11 月至 2019 年 12 月接受 MILS 治疗单个≤3cm HCC 的患者。

结果

714 例患者中,Child-Pugh A 占 641 例(93.0%);65.7%为局限性切除术,2.2%为广泛切除术,转化率为 5.2%。90 天死亡率为 0.3%。总体发病率为 22.4%(3.8%为严重并发症)。平均术后住院时间为 5 天。机器人切除术的手术时间较长(p = 0.004),总发病率较高(p < 0.001),但严重并发症相似(p = 0.431)。Child-Pugh B 患者的死亡率(p = 0.017)和总发病率(p = 0.021)更高,术后住院时间更长(p = 0.005)。5 年总生存率为 79.5%;肝硬化、卫星微结节和微血管侵犯与生存独立相关。

结论

MILS 治疗≤3cm HCC 的发病率和死亡率低,安全性高,支持对这些患者进行手术切除的适应证不断扩大。

相似文献

1
Short and long-term outcomes after minimally invasive liver resection for single small hepatocellular carcinoma: An analysis of 714 patients from the IGoMILS (Italian group of minimally invasive liver surgery) registry.单发性小肝细胞癌微创肝切除术后的短期和长期结果:来自 IGoMILS(意大利微创肝外科组)注册研究的 714 例患者分析。
HPB (Oxford). 2023 Jun;25(6):674-683. doi: 10.1016/j.hpb.2023.02.007. Epub 2023 Feb 24.
2
Technical feasibility and short-term outcomes of laparoscopic isolated caudate lobe resection: an IgoMILS (Italian Group of Minimally Invasive Liver Surgery) registry-based study.腹腔镜孤立尾状叶切除术的技术可行性和短期结果:一项基于 IgoMILS(意大利微创肝外科组)登记研究。
Surg Endosc. 2022 Feb;36(2):1490-1499. doi: 10.1007/s00464-021-08434-w. Epub 2021 Mar 31.
3
Minimally invasive treatment of colorectal liver metastases: does robotic surgery provide any technical advantages over laparoscopy? A multicenter analysis from the IGoMILS (Italian Group of Minimally Invasive Liver Surgery) registry.结直肠肝转移的微创治疗:机器人手术相对于腹腔镜手术是否具有任何技术优势?来自 IGoMILS(意大利微创肝外科组)注册中心的多中心分析。
Updates Surg. 2022 Apr;74(2):535-545. doi: 10.1007/s13304-022-01245-1. Epub 2022 Jan 31.
4
Is minimally invasive liver surgery a reasonable option in recurrent HCC? A snapshot from the I Go MILS registry.微创肝切除术在复发性 HCC 中是否是一种合理的选择?来自 I Go MILS 登记处的快照。
Updates Surg. 2022 Feb;74(1):87-96. doi: 10.1007/s13304-021-01161-w. Epub 2021 Oct 3.
5
Laparoscopic liver resection of hepatocellular carcinoma located in unfavorable segments: a propensity score-matched analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry.腹腔镜肝切除术治疗位于不利部位的肝细胞癌:来自意大利微创肝外科组(I Go MILS)登记处的倾向评分匹配分析。
Surg Endosc. 2019 May;33(5):1451-1458. doi: 10.1007/s00464-018-6426-3. Epub 2018 Sep 10.
6
Diffusion, outcomes and implementation of minimally invasive liver surgery: a snapshot from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry.微创肝脏手术的扩散、结果与实施:来自I Go MILS(意大利微创肝脏手术小组)登记处的快照
Updates Surg. 2017 Sep;69(3):271-283. doi: 10.1007/s13304-017-0489-x. Epub 2017 Aug 31.
7
Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis.建立预测 Child-Pugh B 级肝硬化肝癌患者肝切除术后结局的列线图。
J Hepatol. 2020 Jan;72(1):75-84. doi: 10.1016/j.jhep.2019.08.032. Epub 2019 Sep 6.
8
Surgical Management of Hepatic Benign Disease: Have the Number of Liver Resections Increased in the Era of Minimally Invasive Approach? Analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry.肝良性疾病的外科治疗:微创时代的肝切除术数量增加了吗?来自 I Go MILS(意大利微创肝外科组)注册研究的分析。
J Gastrointest Surg. 2020 Oct;24(10):2233-2243. doi: 10.1007/s11605-019-04260-7. Epub 2019 Sep 10.
9
Ten years of Italian mini-invasiveness: the I Go MILS registry as a tool of dissemination, characterization and networking.十年的意大利微创探索:I Go MILS 登记作为传播、特征和网络构建的工具。
Updates Surg. 2023 Sep;75(6):1457-1469. doi: 10.1007/s13304-023-01597-2. Epub 2023 Jul 24.
10
Robotic and laparoscopic liver resection-comparative experiences at a high-volume German academic center.机器人和腹腔镜肝切除术——德国一家高容量学术中心的比较经验。
Langenbecks Arch Surg. 2021 May;406(3):753-761. doi: 10.1007/s00423-021-02152-6. Epub 2021 Apr 8.

引用本文的文献

1
Minimally invasive hepatectomy thermoablation for single small (≤3 cm) hepatocellular carcinoma: A weighted real-life national comparison.单发性小(≤3 cm)肝细胞癌的微创肝切除术与热消融术:一项基于全国实际情况的加权比较。
JHEP Rep. 2025 Apr 25;7(8):101420. doi: 10.1016/j.jhepr.2025.101420. eCollection 2025 Aug.
2
Recurrence and survival after robotic vs laparoscopic liver resection in very-early to early-stage (BCLC 0-A) hepatocellular carcinoma.极早期至早期(BCLC 0-A期)肝细胞癌机器人手术与腹腔镜肝切除术后的复发及生存情况
Surg Endosc. 2025 Mar;39(3):2116-2128. doi: 10.1007/s00464-025-11553-3. Epub 2025 Feb 4.
3
Robotic, laparoscopic, and open liver resection for hepatocellular carcinoma: A propensity score matched analysis of perioperative outcomes.
肝细胞癌的机器人手术、腹腔镜手术及开腹肝切除术:围手术期结局的倾向评分匹配分析
Surg Pract Sci. 2023 Jun 28;14:100196. doi: 10.1016/j.sipas.2023.100196. eCollection 2023 Sep.
4
Emerging Prognostic Markers in Patients Undergoing Liver Resection for Hepatocellular Carcinoma: A Narrative Review.肝细胞癌肝切除患者新出现的预后标志物:一项叙述性综述。
Cancers (Basel). 2024 Jun 10;16(12):2183. doi: 10.3390/cancers16122183.
5
What Is the Role of Minimally Invasive Liver Surgery in Treating Patients with Hepatocellular Carcinoma on Cirrhosis?微创肝脏手术在治疗肝硬化合并肝细胞癌患者中起什么作用?
Cancers (Basel). 2024 Feb 28;16(5):966. doi: 10.3390/cancers16050966.
6
Ten years of Italian mini-invasiveness: the I Go MILS registry as a tool of dissemination, characterization and networking.十年的意大利微创探索:I Go MILS 登记作为传播、特征和网络构建的工具。
Updates Surg. 2023 Sep;75(6):1457-1469. doi: 10.1007/s13304-023-01597-2. Epub 2023 Jul 24.